• CompanyTop_Icon_Nav
    • About ATI
    • Management
    • Board of Directors
    • Investors
  • Therapy
    • SPG Stimulation
    • ATI System
    • Implant Procedure
  • Clinical Trials
    • Pathway M-1 Migraine Study
  • News
    • News & Updates
  • Careers
    • Careers at ATI
  • Contact
    • Contact Information
Board of Directors

Christopher M. Coburn – Executive Director, Cleveland Clinic Innovations
Frank Fischer (Chairman of the Board) – Chief Executive Officer, Neuropace
Sami Hamadé – Partner, Aberdare Ventures
Gil Kliman, M.D. – General Partner, InterWest Partners
Joe Lacob – Partner, Kleiner Perkins Caufield and Byers
Ben Pless – Chief Executive Officer, Autonomic Technologies
Ali Rezai, MD – Professor Neurological Surgery, Ohio State University
Kevin Wasserstein – Managing Director, Versant Ventures
Steve Weinstein – Managing Director, Novartis Venture Funds

MDMA
 
© 2011 Autonomic Technologies, Inc. All Rights Reserved. Last updated: 26 January 2012